Special Practice Responsibilities
Vice President of Quality Institutional Assurance, Integrity and Compliance (QIAIC) – CBLPath
Compliance Officer - CBLPath
Mr. Laino has more than 35 years of anatomic pathology, cytopathology and laboratory experience, 29 of which are in management and administration. He joined CBLPath immediately following their acquisition in 2003 as the Director of Laboratory Operations. Mr. Laino was instrumental in laboratory business development as the company began expanding its test menu and played a leadership role in obtaining New York State testing category permits in Oncology, Cellular Immunology, Bacteriology, Urinalysis and Cytogenetics as well as operational licensing and practice approval of several off-site satellite laboratory facilities. He initiated the concept behind CBLPath’s information technology quality center module and continued as project consultant until program development and release. This module serves as the foundation for all key quality indicators and the basis for Q-Trend data reporting, risk assessment and auditing. Up until 2011 Mr. Laino also managed the cytopathology department as it grew from 3,000 to 62,000 accessions annually. Prior to joining CBLPath, Mr. Laino served as Chief Operating Officer at a well-known health care institution, successfully overseeing their very lucrative New York Operations Division. He developed and introduced a comprehensive technical and quantitative urine cytopathology program that uses a stoichiometric special stain to better classify pre-malignant and malignant urinary tract disease then further enhanced the program by incorporating red blood cell morphology and sediment analysis to help determine the origin of upper and/or lower urinary tract hematuria. Mr. Laino is currently the Vice President of Quality Institutional Assurance, Integrity and Compliance overseeing the organizations technical and professional quality initiatives, risk management, regulatory, compliance, licensing and safety divisions. Mr. Laino holds a Bachelor of Science in Biology from C.W. Post, Long Island University and a post graduate degree in Cytotechnology from New York-Presbyterian/Weill Cornell Medical Center.